The insulinoma-associated 1: a novel promoter for targeted cancer gene therapy for small-cell lung cancer

[1]  T. Ekström,et al.  HDACi phenylbutyrate increases bystander killing of HSV-tk transfected glioma cells. , 2004, Biochemical and biophysical research communications.

[2]  Joon-Seok Song,et al.  Adenovirus-mediated HSV-TK gene therapy using the human telomerase promoter induced apoptosis of small cell lung cancer cell line. , 2004, Oncology reports.

[3]  A. Argiris,et al.  Progress in the therapy of small cell lung cancer. , 2004, Critical reviews in oncology/hematology.

[4]  J. Cha,et al.  Targeting of therapeutic gene expression to the liver by using liver-type pyruvate kinase proximal promoter and the SV40 viral enhancer active in multiple cell types. , 2004, Biochemical and biophysical research communications.

[5]  M. Breslin,et al.  NeuroD1/E47 Regulates the E-box Element of a Novel Zinc Finger Transcription Factor, IA-1, in Developing Nervous System* , 2003, Journal of Biological Chemistry.

[6]  D. Dean,et al.  Effect of a DNA nuclear targeting sequence on gene transfer and expression of plasmids in the intact vasculature , 2003, Gene Therapy.

[7]  T. Helleday,et al.  DNA repair rate and etoposide (VP16) resistance of tumor cell subpopulations derived from a single human small cell lung cancer. , 2003, Lung cancer.

[8]  D. Hirst,et al.  Transcriptional Targeting in Cancer Gene Therapy , 2003, Journal of biomedicine & biotechnology.

[9]  N. Pedersen,et al.  Transcriptional gene expression profiling of small cell lung cancer cells. , 2003, Cancer research.

[10]  B. Sangro,et al.  Suicide gene therapy mediated by the Herpes Simplex virus thymidine kinase gene/Ganciclovir system: fifteen years of application. , 2003, Current gene therapy.

[11]  Y. Eto,et al.  Expression of progastrin-releasing peptide and gastrin-releasing peptide receptor mRNA transcripts in tumor cells of patients with small cell lung cancer , 2002, Journal of Cancer Research and Clinical Oncology.

[12]  M. Lan,et al.  The zinc-finger transcription factor INSM1 is expressed during embryo development and interacts with the Cbl-associated protein. , 2002, Genomics.

[13]  W. Fisher,et al.  Current Progress in Suicide Gene Therapy for Cancer , 2002, World Journal of Surgery.

[14]  M. Breslin,et al.  Expression of a Novel Zinc-Finger cDNA, IA-1, Is Associated with Rat AR42J Cells Differentiation into Insulin-Positive Cells , 2002, Pancreas.

[15]  M. Breslin,et al.  Neuroendocrine differentiation factor, IA-1, is a transcriptional repressor and contains a specific DNA-binding domain: identification of consensus IA-1 binding sequence. , 2002, Nucleic acids research.

[16]  D. Botstein,et al.  Diversity of gene expression in adenocarcinoma of the lung , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[17]  E. Lander,et al.  Classification of human lung carcinomas by mRNA expression profiling reveals distinct adenocarcinoma subclasses , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[18]  西野 和美.  Adenovirus-mediated gene therapy specific for small cell lung cancer cells using a Myc-Max binding motif , 2001 .

[19]  M. Gondo,et al.  Muscle-specific enhancement of gene expression by incorporation of SV40 enhancer in the expression plasmid , 2001, Gene Therapy.

[20]  M. Black,et al.  Enhanced ganciclovir killing and bystander effect of human tumor cells transduced with a retroviral vector carrying a herpes simplex virus thymidine kinase gene mutant. , 2000, Human gene therapy.

[21]  N. Inase,et al.  Use of gastrin‐releasing peptide promoter for specific expression of thymidine kinase gene in small‐cell lung carcinoma cells , 2000, International journal of cancer.

[22]  L. Smith,et al.  Sequence requirements for plasmid nuclear import. , 1999, Experimental cell research.

[23]  P. Woll,et al.  Tumour-specific arginine vasopressin promoter activation in small-cell lung cancer , 1999, British Journal of Cancer.

[24]  R. Stahel,et al.  The 5′‐flanking region of human CD24 gene has cell‐type‐specific promoter activity in small‐cell lung cancer , 1998, International journal of cancer.

[25]  M. Lan,et al.  Molecular characterization of the promoter region of a neuroendocrine tumor marker, IA-1. , 1997, Biochemical and biophysical research communications.

[26]  D. Dean,et al.  Import of plasmid DNA into the nucleus is sequence specific. , 1997, Experimental cell research.

[27]  T. Kijima,et al.  Eradication of Myc-overexpressing small cell lung cancer cells transfected with herpes simplex virus thymidine kinase gene containing Myc-Max response elements. , 1996, Cancer research.

[28]  C. Richards,et al.  Transcriptional regulatory sequences of carcinoembryonic antigen: identification and use with cytosine deaminase for tumor-specific gene therapy. , 1995, Human gene therapy.

[29]  E. Spindel,et al.  Functional analysis of the 5'-flanking region of the human gastrin-releasing peptide gene in small cell lung carcinoma cell lines. , 1994, Cancer research.

[30]  M. Lan,et al.  Genomic organization, 5'-upstream sequence, and chromosomal localization of an insulinoma-associated intronless gene, IA-1. , 1994, The Journal of biological chemistry.

[31]  K. Yamaguchi,et al.  Pro-gastrin-releasing peptide(31-98) is a specific tumor marker in patients with small cell lung carcinoma. , 1994, Cancer research.

[32]  M. Lan,et al.  IA-1, a new marker for neuroendocrine differentiation in human lung cancer cell lines. , 1993, Cancer research.

[33]  M. Spang‐Thomsen,et al.  Expression of myc family oncoproteins in small‐cell lung‐cancer cell lines and xenografts , 1993, International journal of cancer.

[34]  M. de Silva,et al.  A novel human insulinoma-associated cDNA, IA-1, encodes a protein with "zinc-finger" DNA-binding motifs. , 1992, The Journal of biological chemistry.

[35]  A. Graessmann,et al.  Helper activity for gene expression, a novel function of the SV40 enhancer. , 1989, Nucleic acids research.

[36]  R. Tjian,et al.  Enhancer binding factors AP-4 and AP-1 act in concert to activate SV40 late transcription in vitro , 1988, Nature.

[37]  이현철,et al.  Targeting of therapeutic gene expression to the liver by using liver-type pyruvate kinase proximal promoter and the SV40 viral enhancer active in multiple cell types , 2004 .

[38]  A. Turrisi,et al.  The treatment of limited small cell lung cancer: a report of the progress made and future prospects. , 2002, European journal of cancer.

[39]  M. Tanaka,et al.  Neuron specific enolase promoter for suicide gene therapy in small cell lung carcinoma. , 2001, Anticancer research.

[40]  E. Morimoto,et al.  Adenovirus-mediated suicide gene transfer to small cell lung carcinoma using a tumor-specific promoter. , 2001, Anticancer research.

[41]  A. Malkinson,et al.  Frequent reduction of gap junctional intercellular communication and connexin43 expression in human and mouse lung carcinoma cells. , 1998, Carcinogenesis.

[42]  Peter J. Schaap,et al.  Molecular characterization of the , 1997 .

[43]  G. Fishman,et al.  Gap junctions play a role in the 'bystander effect' of the herpes simplex virus thymidine kinase/ganciclovir system in vitro. , 1996, Gene therapy.

[44]  K. Pavelić,et al.  Molecular genetics of malignant insulinoma. , 1996, Anticancer Research.